Portal de Periódicos da CAPES

KASL clinical practice guidelines: management of chronic hepatitis B

2016; Korean Association for the Study of the Liver; Volume: 22; Issue: 1 Linguagem: Inglês

10.3350/cmh.2016.22.1.18

2287-285X

Hepatitis C virus research

AimsThe clinical practice guidelines for the management of chronic hepatitis B (CHB) were first presented in 2004 by the Korean Association for the Study of the Liver (KASL), and were revised in 2007 and 2011.The American Association for the Study of Liver Diseases (AASLD) published their guidelines in 2015, the European Association for the Study of the Liver (EASL) in 2012, the Asian Pacific Association for the Study of the Liver (APASL) in 2015 and the World Health Organization (WHO) in 2015.These guidelines carry some variations due to ethnic differences and different medical environments.Therefore, there is a demand for Korean practice guidelines which reflect medical practice in Korea.Problems with emergence of drug resistant mutation are eminent in Korea and the KASL updated their guidelines regarding the management of antiviral resistant mutation in 2014.In 2015, the objective of this manuscript was to update the recommendations for management of CHB, including epidemiology, prevention, natural history, diagnosis, treatment, monitoring, drug resistance mutations and treatment of special populations discussed herein based on current evidences or if, evidences lack, on expert opinions after deliberation. KASL clinical practice guidelines: management of chronic hepatitis BThe Korean Association for the Study of the Liver (KASL)*